TransGenRx's Seed Round

TransGenRx raised a round of funding on , . Investors include Louisiana Emerging Technology Center.

TransGenRx produces proinsulin by using proprietary vector technology to transfer a gene of interest into male and female poultry. The result is stable and heritable insertion for the expression of p…

Articles about TransGenRx's Seed Round: